SIRT1 and Age-related Macular Degeneration

Editorial

Austin J Clin Pathol. 2016; 3(1):1040.

SIRT1 and Age-related Macular Degeneration

Ouyang S¹ and Guo H²*

¹Department of Ophthalmology, Central South University, China

²Zhengzhou Aier Eye Hospital, Aier School of Ophthalmology, Central South University, China

*Corresponding author: Guo H, Department of Ophthalmology, Central South University, #99 Hanghai Road, Zhengzhou Aier Eye Hospital, Zhengzhou, 45000, China

Received: May 21, 2016; Accepted: May 23, 2016; Published: May 24, 2016

Editorial

Age-related Macular Degeneration (AMD) is the leading cause of irreversible central vision loss in the elderly [1–3]. AMD is a complex disorder from the interaction of aging with multiple genetic and environmental risk factors. The late stage of AMD can manifest as either Geographic Atrophy (GA) or Choroidal Neo Vascularization (CNV). The pathogenesis of AMD is still under-investigation. Recently, the abnormal of epigenetic factors such as DNA methylation and histone acetylation/ deacetylation have been recognized as an important contributor for the development of AMD, and one of the hot topic in the study of the involvement of epigenetic factors is the histone deacetylase enzyme Mammalian Sirtuin 1 (SIRT1) [4-9].

SIRT1 is a histone deacetylase converting enzyme, functioning as a NAD+-dependent histone deacetylase [10]. SIRT1 regulates cell senescence, DNA damage repair, apoptosis [11] and longevity in response to caloric restriction in many organisms, including yeast, worms, flies, and possibly mammals [12]. SIRT1 plays an important role in normal and pathologic conditions [13]. Recently, SIRT1 has been shown not only to affect histone acetylation but also to target a variety of non-histone proteins, including p53, nuclear factor-kappa B (NF-κB), E2F1, peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and Hypoxia-Inducible Transcription Factors (HIF) [14,15].

SIRT1 is probably involved in the pathogenesis of AMD from some of recent reports. Peng C. et al. displayed that SIRT1 expression was down-regulated in both aged human retina and aged RPE cells from both AMD and non-AMD donors [16]. In addition, the SIRT1 mRNA expression level and self-renewal ability were significantly decreased with age in retinal stem cells, whatever from rats or humans. Although different SIRT1 expression levels were showed in these articles, at least the results suggest that SIRT1 plays a role in the pathogenesis of the disease. Dysfunction and apoptosis of RPE cells are well known major factors that contribute to the pathogenesis of AMD. In young RPE cells, basal levels of p53 were low. By contrast, aged RPE showed increased expression of P53, which is a pro-apoptotic factor as a downstream of SIRT1 [17]. Further study revealed that aging robustly increased p53 phosphorylation and acetylation, which disrupt the interactions of P53 with Mdm2, leading to P53 stabilization [17]. On the other side, pretreatment of cells with resveratrol (a SIRT1 activator) significantly prevented increases of P53 acetylation and phosphorylation and eventually inhibited caspase-3-dependent RPE apoptosis.

Inflammation plays a major role in the pathogenesis of AMD. Amyloid beta (Aβ), a known constituent of drusen, can induce chronical inflammation [18]. Interesting, SIRT1 is also an inflammatory inhibitor. Treatment with SRT1720, a potent SIRT1 agonist, significantly attenuated Aβ-induced upregulation of interleukin (IL)-6, IL-8, and matrix metalloproteinase-9 (MMP- 9), whereas the inhibitory effects of SRT1720 on Aβ-induced upregulation of IL-6, IL-8, and MMP-9 were attenuated in the cells in which SIRT1 expression was knocked down [18]. In addition, pretreatment with SRT1720 inhibited the deleterious effects of Aβ on morphology and barrier function of RPE monolayers. Knockdown of SIRT1 significantly abolished the protective effect of SRT1720 on Aβ-induced barrier disruption [18]. The nuclear factor-kappa B (NF-κB) has been recognized as key inflammation switch. SIRT1 inhibits NF-κB activation and in contrast, NF-κB signaling and inflammatory response can suppress the SIRT1 activity [19]. SIRT1 activation attenuated Aβ-induced inflammation by suppressing NF- κB activation, the transcription of which regulates expression of IL- 6, IL-8, and MMP-9. These results demonstrated that Aβ-induced inflammation and RPE barrier disruption are regulated by the SIRT1/ NF-κB pathway [18].

CNV causes more serious and rapid vision loss than other forms of AMD. Previous studies described the key role of SIRT1 as a critical regulator of angiogenesis [20,21]. The expression of SIRT1 is more frequent in human CNV membranes than non-AMD donor eyes [22]. Another study demonstrated that hypoxia initiates SIRT1 and augments HIF-2α, which in turn activates and releases VEGF [23]. Inhibiting the activity of SIRT1 properly is a promising method to cure retinal neo vascular diseases. Interestingly, other reports showed different results, in vitro study, treatment ARPE-19 cells with SIRT1 inhibitor (nicotinamide) lead to decreased secretion of certain proangiogenic factors, such as VEGF-A, platelet-derived growth factor B Band angiogenin [22]. Further, resveratrol suppressed VEGF secretion induced by inflammatory cytokine (IFN-ɣ, TNF-a, IL-1β), TGF-β and hypoxia without influencing anti-angiogenic endostatin and PEDF secretion [24]. Another experiment revealed that SIRT1 pathway is involved in the mechanism of resveratrol inhibiting hypoxic-induced choroidal vascular endothelial cells proliferation through down-regulating the levels of HIF-1a, thus inhibiting VEGF secretion [25] as well as promoting apoptosis through SAPK/JNK pathway. Khan A et al., demonstrated that resveratrol can inhibit pathological angiogenesis both within and outside the eye in vivo and in vitro by a SIRT1-independent pathway [26]. The discrepancy of the effects of SIRT1 on angiogenesis may be due to the different activators or inhibitors used indifferent experiments and the other conditions used in the different experiments. Further studies should be performed to identify the accurate effect of SIRT1 on CNV formation.

Taken together, SIRT1 may be important for maintaining RPE cells function and protecting them from apoptosis induced by oxidative stress or chronic inflammation damage. However, there are still some controversies regarding the function of SIRT1 in the pathogenesis of AMD, for example, are SIRT1 an angiogenesis inducer or inhibitor in neovascularization in CNV and are the SIRT1 activators suitable for the application in the treatment of human AMD? Further research is needed for clarify these questions.

References

  1. Cooke Bailey JN, Hoffman JD, Sardell RJ, Scott WK, Pericak-Vance MA, Haines JL. The Application of Genetic Risk Scores in Age-Related Macular Degeneration. A Review J Clin Med. 2016; 4; 5.
  2. Ratnapriya R, Chew EY. Age-related macular degeneration-clinical review and genetics update. Clin Genet. 2013; 84: 160-166.
  3. Sobrin L, Seddon JM. Nature and nurture- genes and environment- predict onset and progression of macular degeneration. Prog Retin Eye Res. 2014; 40: 1-15.
  4. Chen Z, Zhai Y, Zhang W, Teng Y, Yao K. Single Nucleotide Polymorphisms of the Sirtuin 1 (SIRT1) Gene are Associated With age-Related Macular Degeneration in Chinese Han Individuals: A Case-Control Pilot Study. Medicine (Baltimore). 2015; 94: 2238.
  5. Li L, Wei W, Zhang Y, Tu G, Zhang Y, Yang J, et al. SirT1 and STAT3 protect retinal pigmented epithelium cells against oxidative stress. Mol Med Rep. 2015; 12: 2231-2238.
  6. Wei W, Li L, Zhang Y, Geriletu, Yang J, Zhang Y, et al. Vitamin C protected human retinal pigmented epithelium from oxidant injury depending on regulating SIRT1. Scientific World Journal. 2014; 750634.
  7. Zhuge CC, Xu JY, Zhang J, Li W, Li P, Li Z, et al. Fullerenol protects retinal pigment epithelial cells from oxidative stress-induced premature senescence via activating SIRT1. Invest Ophthalmol Vis Sci. 2014; 55: 4628-4638.
  8. Nagineni CN, Raju R, Nagineni KK, Kommineni VK, Cherukuri A, Kutty RK, et al. Resveratrol Suppresses Expression of VEGF by Human Retinal Pigment Epithelial Cells: Potential Nutraceutical for Age-related Macular Degeneration. Aging Dis. 2014; 5: 88-100.
  9. Zhang H, He S, Spee C, Ishikawa K, Hinton DR. SIRT1 mediated inhibition of VEGF/VEGFR2 signaling by Resveratrol and its relevance to choroidal neovascularization. Cytokine. 2015; 76: 549-552.
  10. Imai S, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000; 403: 795-800.
  11. Tucci P. Caloric restriction: is mammalian life extension linked to p53? Aging (Albany NY). 2012; 4: 525-534.
  12. Longo VD, Kennedy BK. Sirtuins in aging and age-related disease. Cell. 2006; 126: 257-268.
  13. Menzies KJ, Hood DA. The role of SirT1 in muscle mitochondrial turnover. Mitochondrion. 2012; 12: 5-13.
  14. Lim JH, Lee YM, Chun YS, Chen J, Kim J E, Park JW. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell. 2010; 38: 864-878.
  15. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard, R. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science. 2009; 324: 1289-1293.
  16. Peng CH, Cherng JY, Chiou GY, Chen YC, Chien CH, Kao CL, et al. Delivery of Oct4 and SirT1 with cationic polyurethanes-short branch PEI to aged retinal pigment epithelium. Biomaterials. 2011; 32: 9077-9088.
  17. Bhattacharya S, Chaum E, Johnson DA, Johnson LR. Age-related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53-Mdm2 association. Invest Ophthalmol Vis Sci. 2012; 53: 8350-8366.
  18. Cao L, Liu C, Wang F, Wang H. SIRT1 negatively regulates amyloid-betainduced inflammation via the NF-κB pathway. Braz J Med Biol Res. 2013; 46: 659-669.
  19. Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. See comment in PubMed Commons below Cell Signal. 2013; 25: 1939-1948.
  20. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007; 21: 2644-2658.
  21. Potente M, Dimmeler S. Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle. 2008; 7: 2117-2122.
  22. Maloney SC, Antecka E, Granner T, Fernandes B, Lim LA, Orellana ME, et al. Expression of SIRT1 in choroidal neovascular membranes. Retina. 2013; 33: 862-866.
  23. Balaiya S, Khetpal V, Chalam KV. Hypoxia initiates sirtuin1-mediated vascular endothelial growth factor activation in choroidal endothelial cells through hypoxia inducible factor-2a. Mol Vis. 2012; 18: 114-120.
  24. Nagineni CN, Raju R, Nagineni KK, Kommineni VK, Cherukuri A, Kutty RK. Resveratrol Suppresses Expression of VEGF by Human Retinal Pigment Epithelial Cells: Potential Nutraceutical for Age-related Macular Degeneration. Aging Dis. 2014; 5: 88-100.
  25. Balaiya S, Murthy RK, Chalam KV. Resveratrol inhibits proliferation of hypoxic choroidal vascular endothelial cells. Mol Vis. 2013; 19: 2385-2392.
  26. Khan AA, Dace DS, Ryazanov AG, Kelly J, Apte RS. Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway. Am J Pathol. 2010; 177: 481-492.

Download PDF

Citation: Ouyang S and Guo H. SIRT1 and Age-related Macular Degeneration. Austin J Clin Pathol. 2016; 3(1): 1040. ISSN : 2381-9170

Home
Journal Scope
Online First
Current Issue
Editorial Board
Instruction for Authors
Submit Your Article
Contact Us